Stock Ratings | Morgan Stanley raised its price target for SanDisk (SNDK) to $1,750; HC Wainwright initiated coverage of Upstream Bio (UPB) with a buy rating and a price target of $36, representing a potential upside of 371.82%.
Solid Biosciences Inc. SLDB | 0.00 | |
Rezolute RZLT | 0.00 | |
UpStream Bio UPB | 0.00 | |
Heron Therapeutics Inc HRTX | 0.00 | |
Vir Biotechnology VIR | 0.00 |
The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.
Risk warning:
Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.
Today's key assessments and concerns
HC Wainwright & Co.: Maintaining a "buy" rating on Solid Biosciences Inc.(SLDB.US) ) stock, with a price target raised from $20 to $25.
Maxim Group: Maintaining a "buy" rating on Rezolute ( Rezolute(RZLT.US) ), while raising the target price from $10 to $14.
Citizens: Upgrades Rezolute ( Rezolute(RZLT.US) ) stock to "Outperform," with a price target of $11.
HC Wainwright & Co.: Initial rating for Upstream Bio ( UpStream Bio(UPB.US) ) at "Buy", with a target price of $36.
HC Wainwright & Co.: Maintaining a "buy" rating on Heron Therapeutics ( Heron Therapeutics Inc(HRTX.US) ), while lowering the price target from $4 to $2.
| The symbol | Classification | Target price | Current price | Percentage of potential increase/decrease | (Classification) Agency |
| Solid Biosciences Inc.(SLDB.US) | to lift | $25.0 | $6.85 | 264.96% | HC Wainwright & Co. |
| Rezolute(RZLT.US) | to lift | $14.0 | $4.58 | 205.68% | Maxim Group |
| Rezolute(RZLT.US) | to lift | $11.0 | $4.58 | 140.17% | Citizens |
| Vir Biotechnology(VIR.US) | to lift | $21.0 | $8.77 | 139.45% | Leerink Partners |
| NextNav Inc.(NN.US) | to lift | $50.0 | $21.57 | 131.8% | Oppenheimer |
| UpStream Bio(UPB.US) | Initial classification | $36.0 | $7.63 | 371.82% | HC Wainwright & Co. |
| Heron Therapeutics Inc(HRTX.US) | cut | $2.0 | $0.4468 | 347.63% | HC Wainwright & Co. |
| PicS N.V. Class A(PICS.US) | cut | $18.0 | $9.03 | 99.34% | RBC Capital |
| Celcuity Inc.(CELC.US) | cut | $171.0 | $88.95 | 92.24% | Craig-Hallum |
| Chewy(CHWY.US) | cut | $40.0 | $21.04 | 90.11% | Mizuho |
comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)
Lifting
Morgan Stanley: Maintaining an "overweight" rating on Micron Technology Micron Technology, Inc.(MU.US) , while raising the price target from $520 to $1050.
Stephens & Co.: Maintaining a "Market-Similar Weight" rating for Palo Alto Networks ( Palo Alto Networks, Inc.(PANW.US) ), while raising the price target from $180 to $300.
JP Morgan: Maintaining Palo Alto Networks’ Palo Alto Networks, Inc.(PANW.US) ) rating at “overweight”, while raising the price target from $300 to $326.
Lake Street: Maintaining a "buy" rating on Quantum ( Quantum Corporation(QMCO.US) ), while raising the price target from $8 to $20.
Morgan Stanley: Maintaining SanDisk's ( Sandisk Corporation(SNDK.US) ) rating at "overweight", while raising the price target from $1100 to $1750.
BTIG: Maintain Snowflake(SNOW.US) 's rating at "Buy", while raising the price target from $280 to $325.
Piper Sandler: Maintaining Snowflake(SNOW.US) 's rating at "overweight", while raising the price target from $295 to $320.
First Coverage
Clear Street: Amprius Technologies(AMPX.US) ) stock has a preliminary "buy" rating, with a target price of $33.
TD Cowen: Initial rating for Merlin ( Merlin, Inc.(MRLN.US) ) stock at "Buy", with a target price of $11.
Bernstein: Initial rating for Viking Holdings Viking Holdings Ltd(VIK.US) ) stock at "outperform", with a target price of $120.
reduction
Morgan Stanley: Maintaining an "underweight" rating on FedEx ( FedEx Corporation(FDX.US) ), while lowering the price target from $230 to $160.
UBS: Maintaining the XP ( XP Inc.(XP.US) ) rating at "Buy", while lowering the target price from $28 to $25.
HSBC: Lowered its rating on Thermo Thermo Fisher Scientific Inc.(TMO.US) ) to "Hold," with a price target cut from $670 to $540.
RBC Capital: Maintaining PICS's ( PicS N.V. Class A(PICS.US) ) rating at "Outperform Market", while lowering the price target from $19 to $18.
Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.